Answer Addiction

Tag: Senate vote

  • Bill Targeting Opioids Sent By Mail Up For Senate Vote

    Bill Targeting Opioids Sent By Mail Up For Senate Vote

    The STOP Act will require the U.S. Postal Service to collect electronic data on packages being shipped into the country.

    The Senate will likely pass a bill this week that aims to reduce the number of fentanyl shipments coming into the country via the U.S. Postal Service (USPS). 

    The STOP Act, which stands for Synthetics Trafficking and Overdose Prevention, will require the postal service to collect electronic data on packages being shipped into the country, including the sender’s and recipient’s addresses and the contents as described by the sender.

    Right now, only private courier services like FedEx, UPS and DHL require this information, which means that people can send opioids through the postal service and be virtually untraceable. 

    Illicit fentanyl can be easily made in China and shipped to the United States, since a small volume is immensely powerful and profitable. 

    “We are being overrun with fentanyl,” Senator Rob Portman (R-Ohio), who led an 18-month study of illegal imports, told the New York Times. “It is 50 times more powerful than heroin. It is very inexpensive. It is coming primarily from China and coming primarily through our U.S. Postal Service, if you can believe it.”

    In addition to requiring that the postal service gather additional information on packages, the bill would make is possible for the government to levy fines to the postal service if it does not comply. The postal service would also have the authority to block or destroy packages that have not been properly identified.

    Right now, the postal service must “obtain a warrant to inspect the contents of suspect parcels,” according to William Siemer, acting deputy inspector general of USPS, who testified before Congress this year.

    President Trump supports the measures, taking to Twitter to voice his enthusiasm. 

    “It is outrageous that Poisonous Synthetic Heroin Fentanyl comes pouring into the U.S. Postal System from China,” he wrote last month in a tweet. “We can, and must, END THIS NOW! The Senate should pass the STOP ACT—and firmly STOP this poison from killing our children and destroying our country.”

    The STOP Act has been languishing after it was introduced nearly 18 months ago, allowing shipments of opioids to continue. However, the House passed a similar initiative over the summer, prompting the Senate to move on the issue.

    In addition to addressing the dangers of opioid shipments, the bill would also expand access to treatment for infants born dependent on opioids, implement more stringent packaging requirements for some medications, and accelerate research into non-addictive painkillers that could potentially replace opioids. 

    View the original article at thefix.com

  • Canada Moves Closer To Legalizing Recreational Marijuana

    Canada Moves Closer To Legalizing Recreational Marijuana

    Canada is taking a countrywide approach to avoid the issues that have unfolded in the United States, according to one Canadian senator.

    Canada is one step closer to becoming the first major global economy to legalize recreational marijuana, with the Senate passing a legalization plan on Thursday.

    The plan and all its amendments will now move on to the House, according to the BBC. If approved there, legal sales are expected to start within 12 weeks, meaning it could be legal to purchase marijuana in Canada by the end of the summer. 

    According to one Canadian Senator, Canada is taking a countrywide approach to avoid the issues that have unfolded in the United States, where cannabis is legal in some states but prohibited under federal law. 

    “We’ve very much learned from the early mistakes made by some U.S. states and other jurisdictions,” Canadian Sen. Tony Dean, an independent who sponsored the bill in the Senate, told USA Today. “We know we have a national challenge with cannabis. We have some of the highest youth consumption rates in the world, an illegal cannabis market worth upward of $6 billion annually, we know it’s harmful for kids, especially younger kids… and we had a government that wanted to tackle those issues.”

    Having a national system will allow the Canadian government to address these issues above board, according to Roy Bingham, the CEO and co-founder of cannabis data firm BDS Analytics.

    “Canada is creating a normal industry. What we have in the United States is a very abnormal industry,” he said. “In Canada, you see tobacco, alcohol, pharmaceutical companies, all these mainstream industries interested in getting involved.”

    Prime Minister Justin Trudeau ran on a platform of marijuana legalization in 2015. The senate measure will make recreational use and sale of marijuana legal, but it will leave the specifics of the cannabis laws up to each province or state. 

    Marijuana firms, researchers and public health experts will all be watching Canada closely to see how the market for legalized cannabis unfolds. 

    “It’s going to be a bit of a science fiction experience for a while,” Benedikt Fischer, an expert on substance use at Toronto’s biggest psychiatric hospital, told The Guardian. “It’s unique in the world, because it’s happening for the first time in a wealthy country. It’s not like in the U.S., where there are these state experiments. Most people kind of ignore Uruguay. And so the world is really looking at this.”

    One issue will be setting the price of cannabis high enough to prevent new users from getting started with marijuana, but low enough to discourage black market sales. 

    “What I am mainly following … is who will be the new legal growers, and whether authorities manage to get some of the illegal growers to become legal growers,” said Tim Boekhout van Solinge, a Dutch criminologist.

    Other issues including the impact of legalization on use of other drugs and dealing with impaired drivers, will also be closely monitored by policymakers and researchers from around the globe. 

    “They’re waiting to see if the sky’s going to fall,” said Jordan Sinclair, company spokesman for Canopy Growth, a medical marijuana grower in Canada. “[Investors] are waiting to see if all the stigma and all the demonization of this product that’s built up in 90 years of prohibition is true. It’s on us to demonstrate that it’s not.”

    View the original article at thefix.com